News

Report: Sugar accounts for 17% of normal U.S. diet as Type 2 diabetes accounts for $500 billion in global healthcare spending

BY Alaric DeArment

NEW YORK — Nearly all doctors say that the sharp growth in Type 2 diabetes around the world and the obesity epidemic are linked to excess sugar consumption, according to a new report by the Credit Suisse Research Institute.

The institute, part of the global investment bank, released the report Wednesday titled "Sugar: Consumption at a Crossroads," which explores the medical, economic, consumer, corporate and public policy elements of global sugar consumption and what it means for investors.

The report includes a survey of doctors in the United States, Europe and Asia, which found that 90% think that people consuming too much sugar is strongly linked to the growth in diabetes and obesity. The United States, Brazil, Argentina, Australia and Mexico were found to lead global sugar consumption, and added sugars represent 17% of a normal U.S. diet, with more than 40% of added sugars coming from sweetened beverages. In addition, the report found that Type 2 diabetes was growing at 4% per year, and obesity was growing at 1-2%; in 2012, 4.8 million people around the world died of diabetes, compared with 5.6 million who died from illnesses related to smoking, and over 10% of global healthcare spending — totaling $500 billion — went to Type 2 diabetes.

"Although causality is difficult to prove in this area, with such a high percentage of doctors in our proprietary survey confident of this strong link, we cannot ignore the significance and the implications for society and our economy," Stefano Natella, a Credit Suisse research and study author said.

The report looked at the possibility of taxation, saying it was possibly the most effective way to curb consumption, but was less likely to succeed in most places. But the risk of public intervention and awareness would likely force companies to adapt as consumers move toward healthier options that use high-intensity natural sweeteners.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

P.PEEKE says:
Sep-12-2013 01:53 pm

Added and highly processed sugars are certainly an enormous contributing factor to the development of Type 2 diabetes as well as other serious illnesses. I think, however, many of my readers and patients will wonder at this story in the context of their next visit to their local drug store where they probably have to walk a gauntlet of sweet treats and Halloween candy in order to get to the pharmacist in the back of the store.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Allure magazine reveals ‘2013 Best of Beauty Awards’ winners

BY Antoinette Alexander

NEW YORK — Allure magazine announced the 246 winners of the 2013 Best of Beauty Awards at an awards event held Monday at the Lincoln Center in New York City and hosted by editor-in-chief Linda Wells, along with VP and publisher Agnes B. Chapski.

Thousands of beauty products are launched each year as consumer demand continues to grow, driving the expansion of the beauty and personal care industry in the United States to an estimated $72.6 billion by 2016. Allure‘s Best of Beauty Awards identifies the most effective and innovative products in the marketplace through testing of tens of thousands of products by Allure editors and consultation with experts, such as dermatologists, makeup artists, hairstylists, and cosmetic chemists.

Allure‘s Best of Beauty Awards are distinctive from other such editorial endorsements in that editors test products from the entire market and not just those from brands that advertise.

This year’s winners include:

  • The Big Breakthroughs: Fourteen of the most game-changing innovative products of the year, such as the Color Wow Root Cover Up, the Sephora + Pantone IQ Color IQ system, and the T3 Featherweight Luxe 2i hair-dryer.
  • Eyes: The mascaras, liners, and shadows that will make your eyes bigger, brighter, and sexier, such as the L’Oreal Paris Voluminous Lashes Waterproof Mascara, which testing revealed can withstand the sweatiest Spin class but also gently washes away.
  • Hair: The products that will deliver shinier, healthier hair, such as the Pantene AgeDefy Advanced Thickening Treatment, which makes skimpy strands thicker with a daily spritz.
  • Cheap Thrills: The products that cost $10 or less that deliver and stood out from the rest in testing, including CoverGirl Clean Whipped Creme Foundation, which demonstrates remarkable endurance in keeping complexions looking flawless despite being extremely airy and blendable.
  • Skin: The skin care products that deliver the best cleansing, moisturizing, and anti-aging results, such as Elure’s Advanced Lightening Lotion, which diminishes discoloration in four weeks with a natural enzyme.

   
The full results of Allure‘s Best of Beauty Awards can be found at allure.com/go/best-of-beauty and in the October issue, which hits newsstands Sept. 17.
 


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
vaccines in development.jpg
News

PhRMA report lists 271 vaccines in development

BY Alaric DeArment

WASHINGTON — A vaccine to slow the progression of HIV and a monoclonal antibody that protects against influenza are among the nearly 300 vaccines under development by drug makers in the United States, according to a new report by a drug industry trade group.

The Pharmaceutical Research and Manufacturers of America released a report Wednesday showing 271 vaccines under development, all in clinical trials or under Food and Drug Administration review. They include 137 for infectious diseases, 99 for cancers, 15 for allergies and 10 for neurological disorders.

"Biopharmaceutical research companies are working with partners across the ecosystem to apply new scientific approaches to the development of both preventative and therapeutic vaccines," PhRMA president John Castellani said. "The nearly 300 vaccines in the pipeline provide great hope for protecting and improving public health in the United States and across the globe."

In other news, PhRMA announced the recipients of the 2013 Research & Hope Awards, which honors achievements in vaccines research and immunizations by individuals and research teams.

The GlaxoSmithKline Malaria Vaccine Team won the award for biopharmaceutical industry research in vaccine development, for the development of a vaccine against malaria targeted to children in sub-Saharan Africa. The academic and public research award went to National Cancer Institute researchers Douglas Lowy and John Schiller for the discovery of the human papillomavirus vaccine. Linda Yu-Sing Fu and her team, at the Children’s National Medical Center, won the patient and community health award for efforts to increase awareness of the importance of childhood immunizations and deliver them to an at-risk population in the District of Columbia.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?